Mark Watson, MD, PhD

Primary Academic Title

Professor of Pathology and Immunology, Division of Clinical Pathology, Washington University School of Medicine

Research Interest

Identification and characterization of novel gene transcripts associated with breast cancer progression; expression fingerprinting of primary human breast tumors. Key words: Breast cancer, secretoglobins, gene expression profiling DNA microarrays, gene expression, molecular diagnostics.

Education

1992: MD/PhD, neuroscience, Washington University, St. Louis

Selected Research Publications

In2O3 Nanoribbon-Based Field-Effect Transistor Biosensors for Ultrasensitive Detection of Exosomal Circulating microRNA with Peptide Nucleic Acid Probes.

Zhao Z, Mallon K, Chen M, [...] Watson MA, [...] Zhou C
ACS Nano 2025

Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast Cancer.

Metzger Filho O, Ballman K, Campbell J, [...] Watson M, [...] Symmans WF
J Clin Oncol 2025

Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ: The COMET Randomized Clinical Trial.

Hwang ES, Hyslop T, Lynch T, [...] Watson MA, [...] Partridge AH
JAMA 2025

Endocrine-Sensitive Disease Rate in Postmenopausal Patients With Estrogen Receptor-Rich/ERBB2-Negative Breast Cancer Receiving Neoadjuvant Anastrozole, Fulvestrant, or Their Combination: A Phase 3 Randomized Clinical Trial.

Ma CX, Suman VJ, Sanati S, [...] Watson MA, [...] Carey LA
JAMA Oncol 2024

Extrinsic and intrinsic preanalytical variables affecting liquid biopsy in cancer.

Batool SM, Hsia T, Beecroft A, [...] Watson M, [...] Balaj L
Cell Rep Med 2023

The Liquid Biopsy Consortium: Challenges and opportunities for early cancer detection and monitoring.

Batool SM, Yekula A, Khanna P, [...] Watson M, [...] Balaj L
Cell Rep Med 2023

View All Publications

Siteman earns prestigious merit extension from National Cancer Institute

How Siteman is leading the way in personalized brain tumor treatment

Siteman to Welcome First Patients in New Building Dedicated Exclusively to Cancer Care

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

$5.3 million grant supports research into lung cancer recurrence

Couple honors physician with gift for distinguished professorship

Siteman earns prestigious merit extension from National Cancer Institute

Siteman earns prestigious merit extension from National Cancer Institute

How Siteman is leading the way in personalized brain tumor treatment

Treatment
Clinical
How Siteman is leading the way in personalized brain tumor treatment
If you or a loved one have recently been diagnosed with a brain tumor, you likely feel a great deal of fear and have many questions. The brain is the epicenter of who we are,...
Read The Full Story

How Siteman is leading the way in personalized brain tumor treatment

Specialized Programs

Adult Cancer Types

Childhood Cancer Programs

The Siteman Approach

Siteman to Welcome First Patients in New Building Dedicated Exclusively to Cancer Care

Siteman to Welcome First Patients in New Building Dedicated Exclusively to Cancer Care

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Siteman explains what every woman should know about endometrial cancer risk, symptoms and screening

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

Immunity boosting treatment enhances CAR-T cell therapy for blood cancers

$5.3 million grant supports research into lung cancer recurrence

$5.3 million grant supports research into lung cancer recurrence

Couple honors physician with gift for distinguished professorship

Couple honors physician with gift for distinguished professorship

Mark Watson, MD, PhD

Primary Academic Title

Research Interest

Education

Selected Research Publications